MERS -- Israel
We present the 1st serological and molecular survey for MERS-CoV infection among Israeli camelids, from 2012 to 2017. Camels showed an average MERS-CoV seroprevalence of 60.6 percent between 2012-2017 by VNT and an average seroprevalence of 62.9 percent by ELISA between 2015-2017, without any detection of viral RNA in the nasal swabs of the 540 camels. The presence of virus-specific neutralizing antibodies suggests that Israeli camels were exposed to MERS-CoV in the past. The VNT assay was
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?5787312&promed&0
No comments:
Post a Comment